Amniotic Fluid-Derived Stem Cells for Cardiovascular Tissue Engineering Applications

Amniotic Fluid-Derived Stem Cells for Cardiovascular Tissue Engineering Applications

Recent research has demonstrated that a population of stem cells can be isolated from amniotic fluid removed by amniocentesis that are broadly multipotent and nontumorogenic. These amniotic fluid-derived stem cells (AFSC) could potentially provide an autologous cell source for treatment of congenita...

Full description

Bibliographic Details
Main Authors: Petsche Connell, Jennifer, Camci-Unal, Gulden, Khademhosseini, Ali, Jacot, Jeffrey G.
Other Authors: Harvard University--MIT Division of Health Sciences and Technology
Format: Article
Language:en_US
Published: Mary Ann Liebert, Inc. 2013
Online Access:http://hdl.handle.net/1721.1/80377

Internet

http://hdl.handle.net/1721.1/80377

Similar Items